| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |